Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Rebamipide Enema in Active Ulcerative Colitis
jRCT2080220390Phase 2Completed
- Sponsor
- Otsuka Pharmaceutical Co., Ltd.
- Start
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of rebamipide in autoimmune colitis (4 arms), sponsored by Otsuka Pharmaceutical Co., Ltd. Primary endpoint: Clinical improvement rate. Started May 2007; status: completed.
02
Drugs
rebamipide
03
Conditions
autoimmune colitis
Beyond the preview
Go deeper on jRCT2080220390.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220390.